Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-26

FDA Approved: OHTUVAYRE — Original Application (Verona Pharma, Inc.)

View source ↗

Summary

The FDA approved OHTUVAYRE (ensifentrine) under an original application from Verona Pharma. It is indicated for the treatment of chronic obstructive pulmonary d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OHTUVAYRE (ENSIFENTRINE)

Snippet

ORIG AP for OHTUVAYRE (ENSIFENTRINE)